(3R,4R)-1-tert-Butyl 3-ethyl 4-methylpyrrolidine-1,3-dicarboxylate

Catalog No. :
ACGVRK175
CAS No. :
1434126-89-2
Molecular Formula :
C13H23NO4
Molecular Weight :
257.33

IUPAC Name:1-(tert-butyl) 3-ethyl (3R,4R)-4-methylpyrrolidine-1,3-dicarboxylate

(3R,4R)-1-tert-Butyl 3-ethyl 4-methylpyrrolidine-1,3-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$175.00Login to see priceInquiryInquiry
250mg95%$272.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3R,4R)-1-tert-Butyl 3-ethyl 4-methylpyrrolidine-1,3-dicarboxylate
IUPAC Name1-(tert-butyl) 3-ethyl (3R,4R)-4-methylpyrrolidine-1,3-dicarboxylate
MDL No.MFCD18633044
Molecular FormulaC13H23NO4
Molecular Weight257.33
SMILESO=C(N1C[C@H](C(OCC)=O)[C@@H](C)C1)OC(C)(C)C
InChI KeyQGNVVHOIALIBRL-UWVGGRQHSA-N
Synonym1434126-89-2 | trans-1-tert-butyl 3-ethyl 4-methylpyrrolidine-1,3-dicarboxylate | 1895053-81-2 | (3R,4R)-1-tert-Butyl 3-ethyl 4-methylpyrrolidine-1,3-dicarboxylate | 1-O-tert-butyl 3-O-ethyl (3R,4R)-4-methylpyrrolidine-1,3-dicarboxylate | 1-(tert-Butyl) 3-ethyl (3R
CAS No.1434126-89-2
PubChem CID91800950

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACGVRK175 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGVRK175 route product structure diagram
    ACGVRK1751434126-89-2
Inquiry

2. ACGVRK175 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACGVRK175 route product structure diagram
    ACGVRK1751434126-89-2
Inquiry

Comments (0)